Diverse autophagy and apoptosis in myeloid leukemia cells induced by 20(s)-GRh2 and blue LED irradiation

Jianjian Zhuang1, Juxin Yin1,2, Chaojian Xu1

  • 1Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, College of Life Science, Jilin University Changchun 130000 China lvsw@jlu.edu.cn.

RSC Advances
|May 11, 2022
PubMed

Insights

Combining traditional Chinese medicine (20(s)-Ginsenoside) with blue LED therapy enhances leukemia cell death by inducing apoptosis and modulating autophagy. This novel approach shows promise for leukemia treatment.

Area of Science:

  • Oncology
  • Cell Biology
  • Traditional Chinese Medicine

Background:

  • Autophagy and apoptosis are critical in regulating cell death, particularly in leukemia treatment.
  • Understanding their interplay is key to improving anticancer efficacy.
  • 20(s)-Ginsenoside (a traditional Chinese medicine compound) and Blue LED therapy (BL) show potential in leukemia treatment.

Purpose of the Study:

  • To investigate the individual and combined effects of 20(s)-Ginsenoside (GRh2) and Blue LED therapy (BL) on leukemic cell apoptosis and autophagy.
  • To elucidate the relationship between autophagy and apoptosis in response to these treatments.
  • To evaluate the potential of combining GRh2 and BL as an anti-leukemia strategy.

Main Methods:

  • Treatment of leukemia cells with 20(s)-GRh2, BL, and their combination (BL-GRh2).
  • Assessment of apoptosis via reactive oxygen species (ROS) and mitochondrial membrane potential (MMP) analysis, and apoptosis-related gene/protein expression.
  • Analysis of autophagy markers (LC3B, P62) using western blotting.
  • Utilizing autophagy inhibitor (3-MA) and apoptosis suppressor (Z-VAD-FMK) to dissect treatment mechanisms.

Main Results:

  • Both 20(s)-GRh2 and BL individually and in combination induced apoptosis by increasing ROS and disrupting MMP.
  • Autophagy was activated by BL and BL-GRh2, as indicated by LC3B and P62 levels.
  • Inhibition of autophagy by 3-MA suppressed apoptosis in BL and BL-GRh2 treated cells, but enhanced apoptosis with 20(s)-GRh2 alone.
  • Inhibition of apoptosis by Z-VAD-FMK suppressed autophagy in BL and BL-GRh2 treated cells, but enhanced autophagy with 20(s)-GRh2 alone.
  • The combination therapy (BL-GRh2) showed a stronger induction of apoptosis in myeloid leukemia cells.

Conclusions:

  • Autophagy plays a complex, context-dependent role in leukemia cell death induced by different stimuli.
  • The combination of 20(s)-Ginsenoside with Blue LED therapy represents a promising new strategy for anti-leukemia therapy.
  • This integrated approach highlights the potential of combining traditional medicine with physical therapy for cancer treatment.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
4.0K